Published Date: 10 Mar 2023
United States: The US research team recommended using a different agent to enhance the Doppler profile for more accurate measurements.
Read Full NewsFor patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.
Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.
There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.
1.
Charles III, King of Kings, is Cancerous.
2.
Adopted cancer cells and the effects of their presence.
3.
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes
4.
Knowing about and avoiding bladder cancer.
5.
New drug combination shows good results in patients with HPV-negative head and neck cancer
1.
Apheresis vs. IVMP in Cancer Treatment: A Tale of Two Titans
2.
Optimizing Chemotherapy Dosing: From Phase 1 Dose Escalation to Modification
3.
The Truth About Marijuana and Its Effect on Mental Health
4.
Sorafenib: Understanding the science behind a powerful cancer drug
5.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
5.
Navigating the Complexities of Ph Negative ALL - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation